Transscleral Diode Laser Cyclophotocoagulation in Refractory Glaucoma

Basit Öğe Kaydı
dc.contributor.authorBitirgen, Gulfidan
dc.contributor.authorOkka, Mehmet
dc.contributor.authorBozkurt, Banu
dc.contributor.authorDogru, Ismail
dc.contributor.authorKerimoglu, Hurkan
dc.contributor.authorOzturk, Banu Turgut
dc.contributor.authorKamis, Umit
dc.date.accessioned2024-02-23T14:38:20Z
dc.date.available2024-02-23T14:38:20Z
dc.date.issued2012
dc.departmentNEÜen_US
dc.description.abstractPurpose: To evaluate the safety and efficacy of transscleral diode laser cyclophotocoagulation (TSDLC) in advanced glaucoma refractory to medical or surgical treatment. Material and Method: The data of subjects who were treated with TSDLC between 2009 and 2011 were retrospectively reviewed. Intraocular pressure before and after treatment, visual acuity, the number of medications and complications were analysed. Success was defined as final IOP of 6-22 mmHg with or without antiglaucomatous medications. Results: Thirty seven eyes of 37 patients were included in the study. Mean age of patients and mean follow-up time were 61.73 +/- 17.13 years (range: 19-80 years) and 8.06 +/- 5.81 months (range: 3-22 months), respectively. Mean pretreatment IOP was 38.68 +/- 8.94 mmHg and IOP was 26.46 +/- 11.34 mmHg (p<0.01) at the second week, whereas it was 24.97 +/- 10.84 mmHg (p<0.01) at the last visit. IOP of less than 22 mmHg was achieved in 40.5% of eyes at the last visit. Mean treatment number per eye was 1.48 +/- 0.73, and more than one treatment was required in 13 (35.1%) eyes. Preoperative and postoperative mean total antiglaucomatous medications were 3.14 +/- 1.18 and 2.76 +/- 1.23, respectively. No phthisis bulbi or persistent hypotonia developed during the follow-up period. Discussion: TSDLC is an effective and safe method for the treatment of refractory glaucoma. It also served to reduce the number of antiglaucoma medications, thus improving both the quality of life of the patients and their compliance to therapy.en_US
dc.identifier.doi10.4274/tjo.42.04127
dc.identifier.endpage437en_US
dc.identifier.issn1300-0659
dc.identifier.issn2147-2661
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-84872764268en_US
dc.identifier.startpage434en_US
dc.identifier.urihttps://doi.org/10.4274/tjo.42.04127
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16458
dc.identifier.volume42en_US
dc.identifier.wosWOS:000219213800006en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherTurkish Ophthalmological Socen_US
dc.relation.ispartofTurk Oftalmoloji Dergisi-Turkish Journal Of Ophthalmologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectRefractory Glaucomaen_US
dc.subjectDiode Laser Cyclophotocoagulationen_US
dc.subjectIntraocular Pressureen_US
dc.titleTransscleral Diode Laser Cyclophotocoagulation in Refractory Glaucomaen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu